Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breast Cancer Female × abemaciclib × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Breast 1

Conditions

Breast Neoplasms 4 Solid Tumor 1 Prostatic Neoplasms 1 Glioma 1 Glioblastoma 1 Breast Cancer Female 1 Brain Neoplasms 1

Interventions

durvalumab 1 abemaciclib 1 Saline Solution 1 Ketorolac Tromethamine 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04088032 2020-07-16

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Stony Brook University

Phase EARLY_PHASE1 Withdrawn

BreastOther neoplasm

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡